Akriderm ck ointment 15g tube

Description

Composition
Active substance:
100 g of ointment contains: betamethasone dipropionate in terms of 100% substance – 0,064 g, equivalent to 0.05 g of betamethasone, salicylic acid, calculated as 100% substance – 3 g ;.
Excipients:
Liquid paraffin (paraffin oil) – 10 g Vaseline – 100 g
Description:
Translucent ointment from white to white with a yellowish tinge. Presence of weak specific smell.
Product form:
Ointment for external use 0.05% + 3% .Po 15 or 30 g of aluminum into a tube. Each tube together with instructions for use placed in a pile of cardboard.
Contraindications
Hypersensitivity to any of the formulation components, lupus, perioral dermatitis, rosacea (rosacea), trophic ulcers with chronic venous insufficiency, skin tumors (cancer of the skin, nevi, atheroma, epithelioma, melanoma, hemangioma, xanthoma, sarcoma) ; cutaneous manifestations of syphilis, chickenpox, herpes simplex, skin reactions after vaccination, open wounds, lactation, children under 1 year.
Dosage
0.64 mg + 30 mg / g
Indications
Local treatment of dermatoses accompanied by hyperkeratosis: psoriasis, limited and diffuse neurodermatitis, lichen planus, eczema, disgidrotichesky dermatitis, ichthyosis and ihtiozoformnye changes.
Interaction with other drugs
Interactions with other drugs is not revealed.
Overdose
Acute overdose is highly unlikely, however, when excessive or prolonged application of the drug overdose, chronic possible, accompanied by signs of Cushing: hyperglycemia, glycosuria, reversible depression of adrenocortical function, a manifestation of Cushing’s syndrome.
Treatment. Displaying appropriate symptomatic treatment. In the case of chronic toxic recommended a gradual withdrawal of the drug.
pharmachologic effect
Pharmacological group:
Glucocorticosteroid + ectylotic.
Pharmacological properties:
Combined preparation for external use, providing anti-inflammatory, antiallergic, antiseptic and keratolytic action. Betamethasone dipropionate – glucocorticosteroid, has anti-inflammatory, anti-allergic, antiekssudativnoe, anti iprotivozudnoe action. Inhibits leukocyte accumulation, vysvobozhdenielizosomalnyh enzymes and pro-inflammatory mediators in inflammation inhibits phagocytosis, reduced vascular tissue permeability, prevents the formation of inflammatory edema. Salicylic acid provides keratolytic, antimicrobial effect, eliminates the horny layers and promotes deeper penetration glucocorticosteroid.
Pregnancy and breast-feeding
topical glucocorticosteroids safety has not been established in pregnant women; prescription drugs of this group during beremennostiopravdano only if the potential benefits outweigh the possible risk. During pregnancy, this group of drugs should not be used in high doses or for long periods. Not determined whether the topical application of glucocorticosteroids statprichinoy appearance of their mother’s milk, so you should resolve the issue of termination of breastfeeding.
Conditions of supply of pharmacies
Without recipe.
side effects
The local application of glucocorticosteroids can be observed: a burning sensation, irritation, dryness, folliculitis, hypertrichosis, aknepodobnye eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis. With prolonged use, and the use of occlusive dressings – maceration of the skin, secondary infection, skin atrophy, sudamen, purpura. When applied to a broad surface of the body, mainly in children, may cause systemic side effects of corticosteroids and salicylates. When adverse reactions not described in the instructions, you should consult a doctor.
special instructions
If signs of hypersensitivity or skin irritation associated with the use of the drug, should discontinue treatment and patient choose the adequate therapy. For prolonged treatment, when applied to the preparation extensive skin surface, the use of occlusive dressings, and also at deteyvozmozhna systemic absorption of corticosteroids. Children from 1 year the drug is prescribed only under strict indications and under medical supervision, as may develop systemic side effects associated with betamethasone. In applying the drug on extensive surfaces and / or under an occlusive dressing is possible to suppress the hypothalamic-pituitary-adrenal system and the development of Cushing’s symptoms can be observed decrease in excretion of growth hormone, increased intracranial pressure. On the face more often than on other surfaces of the body, after a long lecheniyaglyukokortikosteroidami local action can manifest atroficheskieizmeneniya; treatment in this case should not exceed 5 days. Akriderm® SC ointment is not suitable for use in ophthalmology. Izbegatpopadaniya the drug in the eye. With long-term use of the drug its abolition should be carried out gradually.
Storage conditions
At a temperature of 15 to 25 C.
Keep out of the reach of children.
Dosing and Administration
Outwardly. Akriderm® SC applied thinly to the affected area 2 times a day – morning and evening. Another application frequency can be set to a doctor, on the basis of the severity of disease. In mild cases enough to apply the ointment, as a rule, once a day; in more severe injuries may require more frequent application.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist